Figure 3
Quercitrin did not show cytotoxic effects on hMSCs.
Cells were grown under six different conditions: basal media; basal media with 200 μM quercitrin (QUER); osteogenic media (OS); osteogenic media with 200 μM quercitrin; osteogenic media supplemented with interleukin-1 beta (IL-1β); and osteogenic media supplemented with IL-1β and quercitrin. (A) Cytotoxicity measured after 2 days. Dotted line represents high control (100% cytotoxicity). (B) Metabolic activity measured after 19 days. Values represent the mean ± SEM of two independent experiments. One, two and three symbols represent a significant difference between two groups with P ≤ 0.05, P < 0.01 and P < 0.001, respectively: (*) treatment versus control (vehicle).
